Contrast Media and Reactions Practice Questions

Q: All of the following are used in a patient with decreased renal function (reduced GFR) to avoid contrast nephropathy except?

Mannitol. **Explanation:** Contrast-Induced Nephropathy (CIN) is a significant risk in patients with reduced GFR. The goal of management is to minimize renal vasoconstriction and oxidative stress. **Why Mannitol is the Correct Answer:** Historically, diuretics like **Mannitol** and Furosemide were thought to "flush" the kidneys. However, clinical trials (such as the PRINCE study) have shown that Mannitol is **ineffective** and may actually be **harmful**. It can cause osmotic diuresis leading to dehydration and further renal vasoconstriction, potentially worsening the risk of CIN. Therefore, it is no longer recommended. **Analysis of Other Options:** * **N-acetyl cysteine (NAC):** An antioxidant that scavenges free radicals and induces vasodilation. While its efficacy is debated in recent large trials (PRESERVE), it is still traditionally used in protocols to prevent CIN due to its low cost and safety profile. * **Fenoldopam:** A selective dopamine D1 receptor agonist that causes renal vasodilation. Though not routinely used due to cost and mixed evidence, it is pharmacologically intended to increase renal blood flow. * **Low Osmolar Contrast Media (LOCM):** High osmolar contrast (HOCM) is highly nephrotoxic. Switching to LOCM (e.g., Iohexol) or Iso-osmolar contrast (e.g., Iodixanol) significantly reduces the risk of CIN in high-risk patients. **High-Yield Clinical Pearls for NEET-PG:** * **Most effective preventive measure:** Adequate **Pre-procedure Hydration** with 0.9% Normal Saline is the gold standard. * **Definition of CIN:** An increase in serum creatinine of >0.5 mg/dL or >25% from baseline within 48–72 hours of contrast administration. * **Metformin:** Must be withheld for 48 hours *after* the procedure to avoid lactic acidosis if renal failure occurs.

Q: What type of radiological contrast agent is preferred for demonstrating a tracheoesophageal fistula?

Low osmolar iodine contrast. ### Explanation The primary concern when evaluating a **Tracheoesophageal Fistula (TEF)** is the high risk of contrast aspiration into the lungs or leakage into the mediastinum. **Why Low Osmolar Iodine Contrast (LOCM) is correct:** LOCM (e.g., Iohexol or Iopamidol) is the preferred agent because it is **water-soluble** and **non-ionic**. If aspirated, LOCM is significantly less irritating to the pulmonary mucosa compared to other agents. It does not cause the severe chemical pneumonitis associated with barium, nor the life-threatening pulmonary edema associated with high-osmolar agents. **Analysis of Incorrect Options:** * **A. High Osmolar Iodine Contrast (HOCM):** These agents (e.g., Gastrografin) are hypertonic. If aspirated, they draw fluid into the alveoli via osmosis, leading to **acute pulmonary edema**, which can be fatal. * **C. Gadolinium-DTPA:** This is an MRI contrast agent. It is not used for fluoroscopic swallow studies or for demonstrating fistulous tracts in routine radiography. * **D. Thick Barium Sulfate:** Barium is inert but non-absorbable. If aspirated into the lungs or leaked into the mediastinum through a fistula, it can cause a severe **foreign body granulomatous reaction** and permanent scarring (fibrosis). **Clinical Pearls for NEET-PG:** * **Gold Standard for TEF:** Fluoroscopic swallow study using **LOCM**. * **Barium Contraindication:** Never use barium if a **perforation** or **fistula** is suspected (risk of mediastinitis/peritonitis). * **Water-Soluble Contraindication:** Avoid HOCM (Gastrografin) if **aspiration** is suspected; use LOCM instead. * **Safe Sequence:** In many GI studies, a water-soluble agent is used first to rule out a leak; if negative, barium may follow for better mucosal detail.

Q: Which of the following conditions is associated with contrast nephropathy?

Diabetes nephropathy. **Explanation:** **Contrast-Induced Nephropathy (CIN)** is defined as an acute impairment of renal function (an increase in serum creatinine by >25% or >0.5 mg/dL) occurring within 48–72 hours of intravascular contrast administration. **Why Diabetes Nephropathy is the Correct Answer:** Diabetes mellitus, particularly when associated with pre-existing renal insufficiency (**Diabetic Nephropathy**), is the **single most significant independent risk factor** for developing CIN. The pathophysiology involves contrast-induced renal vasoconstriction leading to medullary ischemia and direct tubular cytotoxicity. In diabetic patients, the baseline oxidative stress and impaired vasodilatory capacity of the renal vasculature significantly potentiate these effects. **Analysis of Incorrect Options:** * **B, C, and D (Hypertension, Malignant Hypertension, Hypertensive Glomerulosclerosis):** While chronic hypertension can lead to renal damage, it is generally considered a secondary risk factor. Hypertension only significantly increases the risk of CIN if it has already progressed to significant **chronic kidney disease (CKD)** with a reduced Glomerular Filtration Rate (GFR). Diabetic nephropathy carries a much higher relative risk compared to hypertensive nephrosclerosis alone. **High-Yield Clinical Pearls for NEET-PG:** * **Most Important Risk Factor:** Pre-existing renal insufficiency (low GFR). * **Most Effective Prophylaxis:** Intravenous hydration with **Isotonic Saline (0.9% NaCl)** or Sodium Bicarbonate before and after the procedure. * **Metformin Warning:** Metformin does not cause CIN, but if CIN occurs, Metformin can accumulate and cause **Lactic Acidosis**. It should be withheld for 48 hours after contrast administration. * **Contrast Choice:** Non-ionic, **iso-osmolar** contrast media (e.g., Iodixanol) carry the lowest risk for nephropathy.

Q: Which of the following investigations must be performed before administering contrast to a patient?

Kidney function test (KFT). **Explanation:** The administration of iodinated contrast media (used in CT scans and angiography) poses a significant risk of **Contrast-Induced Nephropathy (CIN)**. CIN is defined as an acute decline in renal function (increase in serum creatinine by >0.5 mg/dL or >25% from baseline) within 48–72 hours of contrast exposure. Therefore, assessing the **Kidney Function Test (KFT)**—specifically **Serum Creatinine** and the **estimated Glomerular Filtration Rate (eGFR)**—is mandatory to screen for pre-existing renal impairment, which is the strongest risk factor for CIN. **Analysis of Incorrect Options:** * **Liver Function Test (LFT):** While some contrast agents are excreted via the biliary system, hepatic impairment does not significantly increase the risk of acute toxicity or contrast reactions. * **Urine Specific Gravity:** This measures urine concentration and hydration status but is an unreliable indicator of the kidney's ability to clear contrast media compared to eGFR. * **Serum Electrolytes:** While important for general patient management, electrolyte imbalances are not a direct contraindication to contrast nor a primary predictor of contrast-induced injury. **High-Yield Clinical Pearls for NEET-PG:** * **Safe Threshold:** Contrast is generally considered safe if **eGFR >60 mL/min/1.73m²**. Caution is required if eGFR is between 30–60, and it is generally avoided (unless emergency) if **eGFR <30**. * **Prevention:** The most effective preventive measure for CIN is **intravenous hydration** with 0.9% Normal Saline before and after the procedure. * **Metformin:** In patients with renal impairment, Metformin should be withheld for 48 hours after contrast administration to prevent **Lactic Acidosis**. * **MRI Contrast:** For Gadolinium-based agents, the concern is **Nephrogenic Systemic Fibrosis (NSF)** in patients with severe renal failure.

Question 1

A radiologist is reviewing requests for gadolinium-based contrast MRI (ACR Group II agent). In
which of the following clinical scenarios is contrast-enhanced MRI CONTRAINDICATED or requires
special caution?

Accepted Answer

A 60-year-old diabetic male without available renal function tests

Answer

A child with a documented normal renal function test report

Answer

A 50-year-old patient with eGFR of 30 mL/min/1.73 m²

Answer

A 30-year-old healthy male without available renal function tests

Question 2

All of the following are used in a patient with decreased renal function (reduced GFR) to avoid contrast nephropathy except?

Accepted Answer

Mannitol

Answer

N-acetyl cysteine

Answer

Fenoldopam

Answer

Low osmolar contrast media (LOCM)

Question 3

What type of radiological contrast agent is preferred for demonstrating a tracheoesophageal fistula?

Accepted Answer

Low osmolar iodine contrast

Answer

High osmolar iodine contrast

Answer

Gadolinium-DTPA

Answer

Thick barium sulfate suspension

Question 4

Which of the following conditions is associated with contrast nephropathy?

Accepted Answer

Diabetes nephropathy

Answer

Hypertension

Answer

Malignant hypertension

Answer

Hypertensive glomerulosclerosis

Question 5

Which of the following investigations must be performed before administering contrast to a patient?

Accepted Answer

Kidney function test (KFT)

Answer

Liver function test (LFT)

Answer

Urine specific gravity

Answer

Serum electrolytes

Contrast Media and Reactions — MCQs

Contrast Media and Reactions — MCQs

On this page

Practice by Chapter

Want unlimited practice?